Initial experience of a cohort of patients with hypertrophic cardiomyopathy undergoing biventricular pacing

Christopher A Rinaldi1, Senthil Kirubakaran, Clifford A Bucknall

  • 1Cardiothoracic Dept Guys and St Thomas NHS Trust.

Insights

Biventricular pacing offers short-term benefits for some hypertrophic cardiomyopathy patients, reducing outflow tract gradients. However, long-term outcomes varied, with some patients experiencing deterioration or complications.

Area of Science:

  • Cardiology
  • Cardiac Electrophysiology

Background:

  • Hypertrophic cardiomyopathy (HCM) is a condition where dual chamber pacing can improve symptoms and reduce left ventricular outflow tract (LVOT) gradients.
  • However, the effectiveness of biventricular (BIV) pacing in symptomatic HCM patients requires further investigation.

Purpose of the Study:

  • To investigate the use and efficacy of biventricular (BIV) pacing in symptomatic patients with hypertrophic cardiomyopathy (HCM).

Main Methods:

  • Eight symptomatic HCM patients underwent BIV pacing, with ventricular leads in the right ventricle (RV) and coronary sinus.
  • Short-term effects were assessed via echocardiography, while symptoms and exercise tolerance were evaluated after one month of pacing.
  • Long-term follow-up data was collected for up to 5 years.

Main Results:

  • BIV pacing significantly reduced QRS duration compared to RV pacing.
  • LVOT gradients decreased with both RV pacing and BIV pacing, with BIV pacing showing a greater reduction.
  • Six out of eight patients experienced improved exercise time, with three benefiting from RV pacing and three from BIV pacing.

Conclusions:

  • Biventricular pacing demonstrated short-term advantages over RV pacing alone in select HCM patients, particularly in reducing LVOT gradients.
  • Long-term outcomes were mixed, with one patient dying, another experiencing LV dilatation, and a third requiring system explantation.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiac Catheterization II: Right Heart Catheterization01:21

Cardiac Catheterization II: Right Heart Catheterization

Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...